Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survey of adherence to treatment in inflammatory bowel disease. ENADEII study.
Alonso-Abreu I, Alarcón-Fernández O, Carrillo-Palau M, Ramos-López L, Gisbert JP, Chaparro M, Nos P, Jiménez A, Quintero-Carrión E; en representación de GETECCU. Alonso-Abreu I, et al. Gastroenterol Hepatol. 2020 Jun-Jul;43(6):285-292. doi: 10.1016/j.gastrohep.2019.10.007. Epub 2020 Jan 14. Gastroenterol Hepatol. 2020. PMID: 31948830 English, Spanish.
Usefulness of magnetic resonance enterography in the clinical decision-making process for patients with inflammatory bowel disease.
Ramos López L, Hernández Camba A, Rodríguez-Lago I, Carrillo Palau M, Cejas Dorta L, Elorza A, Alonso Abreu I, Vela M, Hidalgo A, Hernández Álvarez-Builla N, Rodríguez GE, Rodríguez Y, Tardillo C, Díaz-Flórez L, Eiroa D, Aduna M, Garrido MS, Larena JA, Cabriada JL, Quintero Carrion E. Ramos López L, et al. Gastroenterol Hepatol. 2020 Oct;43(8):439-445. doi: 10.1016/j.gastrohep.2020.03.007. Epub 2020 Apr 27. Gastroenterol Hepatol. 2020. PMID: 32349904 English, Spanish.
Adherence to subcutaneous biologic treatment for inflammatory bowel disease.
Ramos L, Ramos-Rodríguez J, Barreda R, Gutiérrez-Nicolás F, Carrillo-Palau M, Alonso-Abreu I, Nazco-Casariego J, Quintero E. Ramos L, et al. Gastroenterol Hepatol. 2022 May;45(5):335-341. doi: 10.1016/j.gastrohep.2021.04.011. Epub 2021 May 27. Gastroenterol Hepatol. 2022. PMID: 34051312 English, Spanish.
QRISK3 Performance in the Assessment of Cardiovascular Risk in Patients with Inflammatory Bowel Disease.
Carrillo-Palau M, Hernández-Camba A, Ramos L, Vela M, Arranz L, Hernández Alvarez-Buylla N, Alonso-Abreu I, Hernández-Pérez A, Hernández-Guerra M, Palazuelos C, Llorca J, González-Gay MÁ, Ferraz-Amaro I. Carrillo-Palau M, et al. Among authors: alonso abreu i. J Clin Med. 2021 Sep 11;10(18):4102. doi: 10.3390/jcm10184102. J Clin Med. 2021. PMID: 34575213 Free PMC article.
COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire.
Ramos L, Carrillo-Palau M, Alonso-Abreu I, Reygosa C, Hernández-Alvarez N, Amaral C, Hernández A, Benítez-Zafra F, Pérez-González F, Quintana-Díaz H, Hernandez-Guerra M. Ramos L, et al. Among authors: alonso abreu i. Gastroenterol Hepatol. 2023 Apr;46(4):255-260. doi: 10.1016/j.gastrohep.2022.05.009. Epub 2022 May 21. Gastroenterol Hepatol. 2023. PMID: 35609791 Free PMC article.
35 results